In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee:
Times and Dates:
8:30 a.m.-5:30 p.m., March 3, 2009.
8:30 a.m.-2 p.m., March 4, 2009.
Place: Corporate Square, Building 8, 1st Floor Conference Room, Atlanta, Georgia 30333, telephone (404) 639-8317.Start Printed Page 813
Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 100 people.
Purpose: This council advises and makes recommendations to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the elimination of tuberculosis. Specifically, the Council makes recommendations regarding policies, strategies, objectives, and priorities; addresses the development and application of new technologies; and reviews the extent to which progress has been made toward eliminating tuberculosis.
Matters To Be Discussed: Agenda items include issues pertaining to comprehensive assessment of available TB laboratory services; National Institutes of Health and Centers for Disease Control and Prevention integrated TB research; aberration detection response using genotyping database for outbreaks and other related tuberculosis issues. Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Margie Scott-Cseh, Coordinating Center for Infectious Diseases, Strategic Business Unit, 1600 Clifton Road, NE., M/S E-07, Atlanta, Georgia 30333, telephone (404) 639-8317. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.Start Signature
Dated: December 31, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. E9-88 Filed 1-7-09; 8:45 am]
BILLING CODE 4163-18-P